• Latest
  • Trending

XNK Therapeutics announces study using samples from patients with acute myeloid leukemia (AML)

06.12.2021

Utah Jazz hires David Fizdale as associate general manager – NBA.com

29.06.2022

Musical notes: Blackpink, Shawn Mendes, Britney Spears, Taylor Swift, Ellie Goulding and Joe Jonas – Deltaplex News – Deltaplex News

29.06.2022
Megan Fox says she and Machine Gun Kelly will wed when the universe ‘opens up and gives us the space to do so’ – Yahoo Lifestyle UK

Megan Fox says she and Machine Gun Kelly will wed when the universe ‘opens up and gives us the space to do so’ – Yahoo Lifestyle UK

29.06.2022
Sources: – Atlanta Hawks acquire guard Dejounte Murray from San Antonio Spurs for three first-round picks, Danilo Gallinari – ESPN

Sources: – Atlanta Hawks acquire guard Dejounte Murray from San Antonio Spurs for three first-round picks, Danilo Gallinari – ESPN

29.06.2022
Crypto Analyst Reveals Significant Downside Target For Ethereum, Predicts Bitcoin Bottom Scenario CryptoGlobe

Crypto Analyst Reveals Significant Downside Target For Ethereum, Predicts Bitcoin Bottom Scenario CryptoGlobe

29.06.2022
Microsoft Teams for the web benefits from background effects, CART captions, and more.  -Windows Central

Microsoft Teams for the web benefits from background effects, CART captions, and more. -Windows Central

29.06.2022
Premier League clubs want Neymar as PSG transfer talks heat up – but where would he best go?  – Goal.com

Premier League clubs want Neymar as PSG transfer talks heat up – but where would he best go? – Goal.com

29.06.2022
Alanis Morissette pays tribute to her former teammate Taylor Hawkins in London – Rolling Stone

Alanis Morissette pays tribute to her former teammate Taylor Hawkins in London – Rolling Stone

29.06.2022
Sources: – Atlanta Hawks acquire guard Dejounte Murray from San Antonio Spurs for three first-round picks, Danilo Gallinari – ESPN

Sources: – Atlanta Hawks acquire guard Dejounte Murray from San Antonio Spurs for three first-round picks, Danilo Gallinari – ESPN

29.06.2022
Arsenal ‘talk’ to Jack Wilshere over Under-23 and Under-18 head coaching vacancies, former gunner has ‘very good relationship’ with academy director Per Mertesacker

Arsenal ‘talk’ to Jack Wilshere over Under-23 and Under-18 head coaching vacancies, former gunner has ‘very good relationship’ with academy director Per Mertesacker

29.06.2022
Games with innovative implementation of split-screen co-op – GameRant

Games with innovative implementation of split-screen co-op – GameRant

29.06.2022

Lady Gaga, Jennifer Lopez, Cardi B: the divas who killed in fishnet stockings – IWMBuzz

29.06.2022
Wednesday, June 29, 2022
  • World
  • Economics
  • Sport
    • Basketball
    • Football
    • Nfl
    • Golf
    • F1
    • UFC
  • Technology
  • Culture
    • Arts
  • Media
    • Film
    • Celebs
    • TV
  • LifeStyle
    • Auto
  • Travel
OLTNEWS
  • World
  • Economics
  • Sport
    • Basketball
    • Football
    • Nfl
    • Golf
    • F1
    • UFC
  • Technology
  • Culture
    • Arts
  • Media
    • Film
    • Celebs
    • TV
  • LifeStyle
    • Auto
  • Travel
OLTNEWS
No Result
View All Result

Home » Technology » XNK Therapeutics announces study using samples from patients with acute myeloid leukemia (AML)

XNK Therapeutics announces study using samples from patients with acute myeloid leukemia (AML)

06/12/2021 07:53:26
in Technology
0
0
SHARES
Share on WhatsappShare on Facebook

Related posts

Microsoft Teams for the web benefits from background effects, CART captions, and more.  -Windows Central

Microsoft Teams for the web benefits from background effects, CART captions, and more. -Windows Central

29.06.2022
Games with innovative implementation of split-screen co-op – GameRant

Games with innovative implementation of split-screen co-op – GameRant

29.06.2022

STOCKHOLM, December 6, 2021 / PRNewswire / – XNK Therapeutics AB (“XNK”) today announced that it will conduct a proof of concept study in acute myeloid leukemia (AML) using patient samples from The University of Texas MD Anderson Cancer Center.

The proof of concept study involves determining the feasibility of expanding and activating NK cells from AML patients using XNK’s proprietary platform. The objective is to establish patient selection criteria for a clinical trial using the XNK platform and, ultimately, to develop new therapeutic approaches for patients with AML.

“Autologous treatments have a number of advantages. For example, they do not require pre-conditioning, which can reduce the risk of serious infections, while potentially offering a persistent response,” said Michael uhlin, CSO of XNK Therapeutics.

AML is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. Leukemia can affect red blood cells, white blood cells and platelets. In 2021, there will be around 20,240 new cases of AML and 11,400 deaths in the United States alone, according to the American Cancer Society.

“XNK is currently active in the clinical development and manufacture of autologous natural killer cell products using its proprietary technology platform,” said Johan Liwing, CEO of XNK Therapeutics. “XNK has promising clinical data in multiple myeloma and the scientific rationale for the application of XNK’s technology in other indications, including hematologic and solid cancers, is strong. “

For more information please contact:
Johan Liwing, CEO, XNK Therapeutics
Phone. : +46 706 70 36 75
E-mail: [email protected]

About XNK Therapeutics AB

XNK Therapeutics is a clinical-stage immunotherapy company focused on the prevention and treatment of cancer by developing novel therapies based on NK cells. The company is at the forefront of development of autologous NK cell products using its proprietary technology platform. The company’s technology platform and leading research drug candidate have been developed specifically to target cancers, including settings where allogeneic cell products are not readily applicable. The Company’s objective is for its experimental drug candidate and its proprietary technological platform to constitute key components of future cancer treatments. XNK Therapeutics is headquartered at Stockholm, Sweden. For more information, please visit www.xnktherapeutics.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/xnk-therapeutics-ab/r/xnk-therapeutics-announces-study-in-acute-myeloid-leukemia–aml–patient-samples,c3465933

The following files are available for download:

SOURCE XNK Therapeutics AB

Share this:

  • Twitter
  • Facebook

Like this:

Like Loading...

Related

Previous Post

Russia’s Putin lands in India to boost military, energy ties – Aljazeera.com

Next Post

Evergrande shares in China hit lowest level in 11 years after company said no repayment guarantees – Reuters

Related Posts

Microsoft Teams for the web benefits from background effects, CART captions, and more.  -Windows Central
Technology

Microsoft Teams for the web benefits from background effects, CART captions, and more. -Windows Central

29.06.2022
0

What do you want to knowMicrosoft just announced several features for Teams on the web.The web version of Teams now...

Read more
Games with innovative implementation of split-screen co-op – GameRant

Games with innovative implementation of split-screen co-op – GameRant

29.06.2022
Arm X3 processor gets 25% speed boost, still expected to be slower than a 2021 iPhone – Ars Technica

Arm X3 processor gets 25% speed boost, still expected to be slower than a 2021 iPhone – Ars Technica

29.06.2022

CareDx, Inc. (NASDAQ: CDNA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP reminds investors of the deadline to file a motion as lead plaintiff in a securities class action lawsuit against CareDx Inc. (NASDAQ: CDNA)

29.06.2022

How to use a different ID for Apple One and iCloud | Rant Screen – Rant Screen

29.06.2022

Edge Data Center Management Market Quality and Quantity Analysis | HUAWEI, Alibaba, Amazon – Designer Women – Designer Women

29.06.2022
Load More
Next Post
Evergrande shares in China hit lowest level in 11 years after company said no repayment guarantees – Reuters

Evergrande shares in China hit lowest level in 11 years after company said no repayment guarantees - Reuters

Recent Posts

  • Utah Jazz hires David Fizdale as associate general manager – NBA.com
  • Musical notes: Blackpink, Shawn Mendes, Britney Spears, Taylor Swift, Ellie Goulding and Joe Jonas – Deltaplex News – Deltaplex News
  • Megan Fox says she and Machine Gun Kelly will wed when the universe ‘opens up and gives us the space to do so’ – Yahoo Lifestyle UK
  • Sources: – Atlanta Hawks acquire guard Dejounte Murray from San Antonio Spurs for three first-round picks, Danilo Gallinari – ESPN
  • Crypto Analyst Reveals Significant Downside Target For Ethereum, Predicts Bitcoin Bottom Scenario CryptoGlobe

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • EN

© 2020

No Result
View All Result
  • World
  • Economics
  • Sport
    • Basketball
    • Football
    • Nfl
    • Golf
    • F1
    • UFC
  • Technology
  • Culture
    • Arts
  • Media
    • Film
    • Celebs
    • TV
  • LifeStyle
    • Auto
  • Travel

© 2020

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
%d bloggers like this: